XTAE:PRGO (Ireland)
Business Description
Perrigo Co PLC
NAICS : 325412
SIC : 2834
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Compare
Compare
Traded in other countries / regions
P1RG34.Brazil
•
PIG.Germany
•
PRGO.Israel
•
PRGO.Mexico
•
0Y5E.UK
•
PRGO.USA
Description
Perrigo Co PLC is a leading private label supplier of generic over the counter (OTC) drugs in the U.S. and Europe. The company's product offerings fall under traditional OTC drug categories (i.e. cough, cold, allergy, pain), in addition to oral care, infant nutrition (formula), and nicotine cessation aids. In addition to private label manufacturing, the company also sells products under its own brands (largely in the skincare and oral-care category). The company became a pure-play in OTC consumer healthcare in 2021, following a series of divestitures over several years (sold off generic prescription topicals, animal health, and active pharmaceutical ingredient business). In late 2021, Perrigo signed an offer to acquire HRA Pharma.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.56 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.69 | |||||
| Debt-to-EBITDA | 5.42 | |||||
| Interest Coverage | 4.45 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.23 | |||||
| Beneish M-Score | -2.38 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.3 | |||||
| 3-Year EBITDA Growth Rate | -5.1 | |||||
| 3-Year FCF Growth Rate | -79.4 | |||||
| 3-Year Book Growth Rate | -2.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.13 | |||||
| 9-Day RSI | 41.88 | |||||
| 14-Day RSI | 44.38 | |||||
| 6-1 Month Momentum % | -4.47 | |||||
| 12-1 Month Momentum % | -8.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.01 | |||||
| Quick Ratio | 2.97 | |||||
| Cash Ratio | 2 | |||||
| Days Inventory | 139.57 | |||||
| Days Sales Outstanding | 56.96 | |||||
| Days Payable | 55.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.63 | |||||
| 3-Year Dividend Growth Rate | 8.1 | |||||
| Forward Dividend Yield % | 2.81 | |||||
| 5-Year Yield-on-Cost % | 4.41 | |||||
| 3-Year Average Share Buyback Ratio | 0.5 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.97 | |||||
| Operating Margin % | 13.62 | |||||
| Net Margin % | -2.6 | |||||
| ROE % | -2.06 | |||||
| ROA % | -1.01 | |||||
| ROIC % | -3.98 | |||||
| ROC (Joel Greenblatt) % | 13.48 | |||||
| ROCE % | 3.86 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 17.69 | |||||
| PS Ratio | 1.32 | |||||
| PB Ratio | 1.1 | |||||
| Price-to-Tangible-Book | 74.19 | |||||
| Price-to-Free-Cash-Flow | 51.45 | |||||
| Price-to-Operating-Cash-Flow | 23.66 | |||||
| EV-to-EBIT | 19.98 | |||||
| EV-to-EBITDA | 11.01 | |||||
| EV-to-Revenue | 1.7 | |||||
| EV-to-FCF | 66.02 | |||||
| Price-to-Projected-FCF | 0.72 | |||||
| Price-to-Median-PS-Value | 0.56 | |||||
| Earnings Yield (Greenblatt) % | 5.01 | |||||
| Forward Rate of Return (Yacktman) % | -9.69 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | 13,825.481 | ||
| EPS (TTM) (₪) | -2.861 | ||
| Beta | 0 | ||
| Volatility % | 38.25 | ||
| 14-Day RSI | 44.38 | ||
| 14-Day ATR (₪) | 2.621081 | ||
| 20-Day SMA (₪) | 120.345 | ||
| 12-1 Month Momentum % | -8.22 | ||
| 52-Week Range (₪) | 111.1 - 164.5 | ||
| Shares Outstanding (Mil) | 133.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Perrigo Co PLC Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||